Drug profile · INN
tegaserod maleate
ZELNORM
tegaserod maleate (ZELNORM) is a serotonin 4 (5-ht4) receptor partial agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — tegaserod maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tegaserod maleate (ZELNORM) is a serotonin 4 (5-ht4) receptor partial agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 4 (5-HT4) receptor partial agonist
Primary target: 5-hydroxytryptamine receptor 4
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tegaserod maleate?
tegaserod maleate (ZELNORM) is a serotonin 4 (5-ht4) receptor partial agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tegaserod maleate?
ZELNORM is a marketed brand name for tegaserod maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tegaserod maleate?
tegaserod maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.